cc.\*:("002B04E01")
Results 1 to 25 of 1447
Selection :
An association between clock genes and clock-controlled cell cycle genes in murine colorectal tumorsSOTAK, Matus; POLIDAROVA, Lenka; ERGANG, Peter et al.International journal of cancer (Print). 2013, Vol 132, Num 5, pp 1032-1041, issn 0020-7136, 10 p.Article
Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularizationSMALL, Donna M; BURDEN, Roberta E; WALKER, Brian et al.International journal of cancer (Print). 2013, Vol 133, Num 9, pp 2102-2112, issn 0020-7136, 11 p.Article
MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming ActivityWASYLISHEN, Amanda R; CHAN-SENG-YUE, Michelle; RAUGHT, Brian et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 21, pp 6504-6515, issn 0008-5472, 12 p.Article
REST-dependent expression of TRF2 renders non-neuronal cancer cells resistant to DNA damage during oxidative stressKWON, Jung-Hee; JI HYE SHIN; KIM, Eung-Sam et al.International journal of cancer (Print). 2013, Vol 132, Num 4, pp 832-842, issn 0020-7136, 11 p.Article
The translational landscape of mTOR signalling steers cancer initiation and metastasisHSIEH, Andrew C; YI LIU; SHUNYOU WANG et al.Nature (London). 2012, Vol 485, Num 7396, pp 55-61, issn 0028-0836, 7 p.Article
SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited ConditionsKELLER, Kirstie E; TAN, Irene S; LEE, Young-Sam et al.Science (Washington, D.C.). 2012, Vol 338, Num 6110, pp 1069-1072, issn 0036-8075, 4 p.Article
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cellsFACCIABENE, Andrea; XIAOHUI PENG; COUKOS, George et al.Nature (London). 2011, Vol 475, Num 7355, pp 226-230, issn 0028-0836, 5 p.Article
Evolving Molecular Mechanism-Based Strategies for Control of Hepatocellular CarcinomaSATO, K; MORI, M.Current medicinal chemistry. 2011, Vol 18, Num 28, pp 4375-4388, issn 0929-8673, 14 p.Article
Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor ProgressionSHENG, K. C; WRIGHT, M. D; APOSTOLOPOULOS, V et al.Current medicinal chemistry. 2011, Vol 18, Num 36, pp 5507-5518, issn 0929-8673, 12 p.Article
Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?WILTING, J; HAGEDORN, M.Current medicinal chemistry. 2011, Vol 18, Num 36, pp 5519-5527, issn 0929-8673, 9 p.Article
CD95 promotes tumour growthCHEN, Lina; PARK, Sun-Mi; PETER, Marcus E et al.Nature (London). 2010, Vol 465, Num 7297, pp 492-496, issn 0028-0836, 5 p.Article
Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agentsTATSUZAKI, Jin; NAKAGAWA-GOTO, Kyoko; TOKUDA, Harukuni et al.Journal of Asian natural products research. 2010, Vol 12, Num 3-4, pp 227-232, issn 1028-6020, 6 p.Article
p57: A multifunctional protein in cancer (Review)HUI GUO; TAO TIAN; KEJUN NAN et al.International journal of oncology. 2010, Vol 36, Num 6, pp 1321-1329, issn 1019-6439, 9 p.Article
Voie de signalisation Sonic Hedgehog: du développement embryonnaire aux thérapies moléculaires ciblées = Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapiesWATSON, S; SERRATE, C; VIGNOT, S et al.Bulletin du cancer. 2010, Vol 97, Num 12, pp 1477-1483, issn 0007-4551, 7 p.Article
Sénescence et immortalité cellulaire = Senescence and cellular immortalityTRENTESAUX, C; RIOU, J.-F.Bulletin du cancer. 2010, Vol 97, Num 11, pp 1275-1283, issn 0007-4551, 9 p.Article
La transition épithéliomésenchymateuse au cours du développement dans la fibrose et dans la progression tumorale = Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinomaTHIERY, J.-P; CHUA, K; WEN JING SIM et al.Bulletin du cancer. 2010, Vol 97, Num 11, pp 1285-1295, issn 0007-4551, 11 p.Article
Activation of the P13K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2aFINE, Barry; HODAKOSKI, Cindy; HIBSHOOSH, Hanina et al.Science (Washington, D.C.). 2009, Vol 325, Num 5945, pp 1261-1265, issn 0036-8075, 5 p.Article
WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activityXIAO, Andrew; HAITAO LI; PATEL, Dinshaw J et al.Nature (London). 2009, Vol 457, Num 7225, pp 57-62, issn 0028-0836, 6 p.Article
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor CellsYUN, Jihye; RAGO, Carlo; DIAZ, Luis A et al.Science (Washington, D.C.). 2009, Vol 325, Num 5947, pp 1555-1559, issn 0036-8075, 5 p.Article
Apport des modèles animaux pour l'étude du rôle de K-ras dans l'oncogenèse = Mouse of K-ras-initiated oncogenesisBARRIERE, C; EL MARJOU, F; LOUVARD, D et al.Bulletin du cancer. 2009, Vol 96, Num DEC, issn 0007-4551, S5-S14, NSArticle
Généralités sur la cancérogenèse : Nouveautés en cancérogenèse = Generalities about carcinogenesisTUBIANA, Maurice.Comptes rendus. Biologies. 2008, Vol 331, Num 2, pp 114-125, issn 1631-0691, 12 p.Article
Génomique tumorale : l'image d'un paysage instable = Tumour genomics : an unstable landscapeMOYRET-LALLE, Caroline; FALETTE, Nicole; GRELIER, Gaël et al.Bulletin du cancer. 2008, Vol 95, Num 10, pp 923-930, issn 0007-4551, 8 p.Article
MicroRNA and cancer : Current status and prospectiveWEI WU; MIAO SUN; GANG-MING ZOU et al.International journal of cancer. 2007, Vol 120, Num 5, pp 953-960, issn 0020-7136, 8 p.Article
Transforming growth factor-β signaling in cancer invasion and metastasisLEIVONEN, Suvi-Katri; KÄHÄRI, Veli-Matti.International journal of cancer. 2007, Vol 121, Num 10, pp 2119-2124, issn 0020-7136, 6 p.Article
Adaptive immunity maintains occult cancer in an equilibrium stateKOEBEL, Catherine M; VERMI, William; SWANN, Jeremy B et al.Nature (London). 2007, Vol 450, Num 7171, pp 903-907, issn 0028-0836, 5 p.Article